(Q38347071)

2

1 reference

2 September 2017

Jennifer B Nixon

3

1 reference

2 September 2017

Richard P DiAugustine

4

1 reference

2 September 2017

Thomas E Eling

Journal of Biological Chemistry

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

8 December 2003

1 reference

2 September 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 September 2017

279

1 reference

2 September 2017

6883-6892

1 reference

2 September 2017

8

1 reference

2 September 2017

Peroxisome proliterator-activated receptors, orphans with ligands and functions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Early growth response-1-dependent apoptosis is mediated by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Role of Egr-1 gene expression in B cell receptor-induced apoptosis in an immature B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apoptosis in human and rat hepatoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Interaction of early growth response protein 1 (Egr-1), specificity protein 1 (Sp1), and cyclic adenosine 3'5'-monophosphate response element binding protein (CREB) at a proximal response element is critical for gastrin-dependent activation of the c

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

DNA-binding specificity of NGFI-A and related zinc finger transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

The phosphorylated forms of the transcription factor, Egr-1, bind to DNA more efficiently than non-phosphorylated

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305295200